Brief: Heartbeam Completes $25 Million Capital Raise And Updates 2023 Strategic Focus And Financial Guidance
03/05/2023 13:54
May 3 (Reuters) - Heartbeam Inc BEAT.O :
* HEARTBEAM COMPLETES $25 MILLION CAPITAL RAISE AND UPDATES
2023
STRATEGIC FOCUS AND FINANCIAL GUIDANCE
* HEARTBEAM INC: EXPECT NO MATERIAL COMMERCIAL REVENUE FOR
2023
* HEARTBEAM INC: ADJUSTED ITS STRATEGIC FOCUS TO ENABLE
TIMELY
DELIVERY OF ITS BREAKTHROUGH AMBULATORY VECG PRODUCTS
* HEARTBEAM INC - PLANS TO SUBMIT 510(K) CLEARANCE FOR
12-LEAD
EQUIVALENCE TO FDA IN LATE 2023 & PURSUE INITIAL
COMMERCIALIZATION IN 2024
Source text for Eikon: ID:nBw4fv40ca
Further company coverage: BEAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartBeam
See all newsBrief: Heartbeam Receives FDA Breakthrough Device Designation For Heart Attack Assessment
Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance